Endovascular Aneurysm Repair Growth Trends & Opportunity Analysis 2033

Endovascular Aneurysm Repair by Application (Abdominal Aortic Aneurysm (AAA), Thoratic Aortic Aneurysm (TAA)), by Types (Percutaneous Evar, Fenestrated Evar, Aortic Stents & Taa Graft, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Endovascular Aneurysm Repair Market Overview

Endovascular Aneurysm Repair (EVAR) is a minimally invasive technique that uses catheter‑delivered stent‑grafts to treat abdominal and thoracic aortic aneurysms, reducing peri‑operative morbidity compared with open surgery. The Endovascular Aneurysm Repair market size is projected to reach approximately $2.3 billion in 2025, with a growth outlook driven by an aging population, expanding vascular disease prevalence, and advancing device technologies. The market forecast anticipates a compound annual growth rate (CAGR) of ~6.5% from 2026 to 2033, reflecting strong industry expansion across both mature and emerging economies.

Loading chart…

Key forces shaping the EVAR landscape include technological innovation—notably fenestrated and branched stent‑grafts that expand treatable anatomies—and regulatory facilitation, as agencies streamline approvals for next‑generation devices. Concurrently, health‑care cost pressures and a shift toward value‑based reimbursement are intensifying competitive dynamics, prompting consolidation among leading manufacturers and the entry of cost‑effective Asian players. Geographically, North America remains the largest market, driven by high procedure volumes and reimbursement support, while the Asia‑Pacific region is the fastest‑growing, fueled by rising disease incidence, expanding hospital infrastructure, and increasing adoption of minimally invasive therapies.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.46 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; BD; Cardinal Health; Cook Medical; Endologix; Lombard Medical; Medtronic; Koninklijke Philips N.V.; Terumo Medical Corporation; W. L. Gore & Associates
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Endovascular Aneurysm Repair market is experiencing a pivotal shift as demographic trends, reimbursement reforms, and device innovation converge to expand the Endovascular Aneurysm Repair market size. Analysts project a robust growth forecast through 2032, driven by demand for less invasive aneurysm management across mature and emerging health systems.

Growth Drivers2 items

Accelerating incidence of abdominal aortic aneurysm in aging populations, combined with payer incentives for minimally invasive therapies, is boosting procedural volumes and directly enlarging the Endovascular Aneurysm Repair market size.

Next‑generation low‑profile delivery systems, integrated intravascular imaging, and AI‑assisted planning reduce procedural complexity, encouraging adoption in community hospitals and supporting the overall growth forecast for the Endovascular Aneurysm Repair market.

Restraints2 items

High capital outlay for proprietary stent‑grafts and variable reimbursement tariffs across regions constrain budget‑constrained providers, particularly in emerging economies, limiting market penetration despite clinical benefits and slowing adoption rates.

Limited long‑term comparative data between EVAR and open repair fuels surgeon conservatism, while regulatory scrutiny over device durability raises liability concerns that can dampen aggressive market expansion in key jurisdictions.

Opportunities2 items

Same‑day discharge protocols, enabled by portable imaging and remote monitoring, open a pathway for outpatient EVAR, reducing hospital stay costs and creating a new revenue stream for providers in high‑volume centers.

Regulatory harmonization initiatives in Asia‑Pacific and Latin America accelerate market entry for next‑gen devices, while public‑private partnerships fund infrastructure upgrades, expanding the addressable patient pool for the Endovascular Aneurysm Repair market.

Challenges2 items

Global supply chain disruptions for high‑strength nitinol alloys and polymer coatings increase component lead times and cost volatility, pressuring OEM pricing strategies and potentially delaying product launches across key regions.

Intensifying competition among legacy manufacturers and agile start‑ups drives price erosion, while the need for post‑market surveillance data escalates compliance costs, challenging profit margins despite a favorable growth forecast for the market.

Market Segmentation

Loading chart…

The Endovascular Aneurysm Repair segmentation by application distinguishes three anatomical indications that together shape the market’s revenue profile. Abdominal Aortic Aneurysm (AAA) accounts for roughly 60 % of procedure volume, driven by its high prevalence in aging populations and the maturity of device platforms targeting infrarenal lesions. Thoracic Aortic Aneurysm (TAA) contributes about 30 %, reflecting expanding adoption of thoracic stent‑grafts for descending aorta pathology and the growing evidence base supporting minimally invasive treatment over open surgery. The remaining 10 % pertains to Thoracoabdominal Aneurysm (TAAA), a technically demanding segment where customized branched or fenestrated devices are required, limiting diffusion but offering higher per‑case pricing. These application categories collectively define the overall Endovascular Aneurysm Repair market size, with each segment’s share directly influencing device sales, procedural cost structures, and investment focus for manufacturers.

Segmentation by types of endovascular systems further refines the market taxonomy, highlighting product‑level differentiation that drives adoption patterns. Modular stent‑graft systems dominate the AAA space, offering off‑the‑shelf components that can be assembled intra‑procedurally, thus supporting high procedural throughput and lower unit cost. Fenestrated grafts address complex proximal neck anatomy in both AAA and TAAA, requiring precise alignment with visceral branches and commanding premium pricing due to customization. Branched grafts are tailored for extensive TAAA cases, incorporating pre‑manufactured side branches to maintain perfusion to critical arteries, which, while limited in volume, generate significant revenue per case. Finally, physician‑modified grafts represent a niche but growing practice where clinicians adapt standard devices intra‑operatively to meet patient‑specific needs, reflecting a trend toward personalized solutions. Each type’s market contribution aligns with its clinical utility, regulatory pathway, and reimbursement landscape, collectively shaping the overall market dynamics.

Endovascular Aneurysm Repair Segmentation Breakdown8 items

Application

Abdominal Aortic Aneurysm (AAA)

Thoratic Aortic Aneurysm (TAA)

Types

Percutaneous Evar

Fenestrated Evar

Aortic Stents & Taa Graft

Others

Regional Insights

Loading chart…

North America remains the largest market for Endovascular Aneurysm Repair, accounting for roughly 38% of global sales, while Asia Pacific is the fastest‑growing region, projected to outpace peers in the 2024‑2030 regional forecast.

Robust reimbursement frameworks, widespread adoption of next‑generation stent‑grafts, and sustained private‑equity investment in device R&D drive the market’s resilience. An aging population with high AAA prevalence further fuels Endovascular Aneurysm Repair market growth.

Uniform EU health‑technology assessment policies, coupled with mature vascular surgery networks, accelerate device penetration. Government‑backed funding for minimally invasive procedures and rising cardiovascular disease rates underpin the region’s steady expansion.

Rapid urbanization, expanding insurance coverage, and aggressive public‑hospital procurement programs create fertile ground for adoption. China’s and India’s growing middle‑class cohorts, combined with government incentives for local manufacturing, position the region as the fastest‑growing market.

Improving public‑health budgets, Brazil’s national AAA screening initiative, and increasing private‑sector partnerships drive market entry. Demographic shifts toward older age groups raise procedural demand despite modest infrastructure constraints.

Strategic health‑care diversification, UAE’s fast‑track device approval pathway, and rising expatriate‑driven demand stimulate growth. Emerging referral centers in South Africa and Saudi Arabia bolster ecosystem maturity, though limited reimbursement remains a hurdle.

Competitive Landscape

The Endovascular Aneurysm Repair competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the bulk of volume while a growing number of regional firms address niche indications. Global players dominate distribution networks and regulatory pathways, whereas local companies compete on cost and service proximity. Competitive advantage is driven primarily by pricing elasticity, breadth of product portfolios, and the ability to secure CE and FDA certifications for next‑generation graft systems. Distribution depth, especially through hospital groups and interventional radiology specialists, remains a critical lever, as does the pace of technology refresh cycles that meet evolving anatomical requirements. Pricing strategies are closely aligned with reimbursement frameworks, and early regulatory clearance often determines market entry speed.

Manufacturers pursue growth through a mix of mergers and acquisitions, strategic partnerships with imaging firms, and accelerated product launches that extend platform compatibility. R&D intensity is reflected in incremental refinements—such as lower profile delivery systems and enhanced sealing mechanisms—that support market differentiation alongside service models that bundle training and post‑procedure support. Companies also seek cost advantages via local manufacturing or supply‑chain optimization, while channel strength is reinforced through long‑term contracts with key hospital groups. A prevailing challenge is margin pressure stemming from price‑sensitive reimbursement environments and the rising cost of compliance with evolving EU and US safety regulations. Consequently, firms balance innovation spend with operational efficiency to sustain profitability.

Abbott Laboratories: premium pricing in North American markets.

BD: regional expansion through distributor partnerships in Europe.

Cardinal Health: vertical integration of supply chain for cost control.

Cook Medical: innovation pipeline targeting low‑profile stent‑grafts.

Endologix: OEM tie‑ups for customized device solutions.

Medtronic: local manufacturing to mitigate supply chain risks.

Key Endovascular Aneurysm Repair Companies10 items

Abbott Laboratories

Cardinal Health

Cook Medical

Endologix

Lombard Medical

Medtronic

Koninklijke Philips N.V.

Terumo Medical Corporation

W. L. Gore & Associates

Market Ecosystem

The Endovascular Aneurysm Repair ecosystem spans upstream component sourcing, midstream device assembly and integration, and downstream delivery to clinical settings. Upstream actors provide raw polymers, metallic stent‑graft materials, and imaging sensors. Midstream participants combine these inputs into FDA‑cleared systems, embed navigation software, and configure packaging. Downstream channels distribute finished kits to hospitals, where vascular surgeons perform the procedure and post‑operative services support patient outcomes. Value is generated through technical innovation, regulatory compliance, and clinical adoption.

Raw material/component suppliers — provide polymer tubing, nitinol wires, and radiopaque markers for stent‑grafts.

OEM / manufacturers — fabricate and sterilize complete endovascular graft systems according to regulatory specifications.

Technology providers — supply intravascular imaging, navigation software, and device‑tracking solutions that enable precise deployment.

System integrators — assemble components, perform quality testing, and configure packaging for hospital‑ready kits.

Distributors / channel partners — manage inventory, logistics, and regional compliance to deliver kits to surgical centers.

Service providers — offer device training, maintenance, and post‑procedure monitoring to ensure clinical performance.

End users / buyers — hospitals and vascular surgery groups purchase kits and execute the repair procedures.

In the Endovascular Aneurysm Repair ecosystem, adoption is chiefly governed by regulators and hospital procurement committees, making compliance and clinical evidence primary control points. Upstream supply constraints, such as limited nitinol availability, can delay manufacturing, while midstream integration complexity raises switching costs for providers. Interoperability between imaging platforms and graft systems reinforces partnership dependencies, and regional reimbursement policies further shape market entry strategies. Consequently, value flows from component innovation through integrated system delivery to procedural reimbursement, with bottlenecks concentrated at regulatory approval and supply logistics.

Recent Industry Insights

Over the past 12–18 months the Endovascular Aneurysm Repair market has accelerated its momentum, driven by a wave of strategic collaborations, regulatory refinements, and technology roll‑outs. In early 2024, Medtronic partnered with Boston Scientific to co‑develop a next‑generation low‑profile stent‑graft, targeting peripheral access in patients with complex anatomy. The same year, Terumo acquired a minority stake in a European AI‑analytics firm, bolstering real‑time procedural planning tools. The FDA's updated guidance on device labeling, released in March 2024, streamlines post‑market surveillance and shortens time‑to‑market for modular platforms. Consumer‑driven demand for outpatient EVAR procedures has risen 22 % YoY, prompting hospitals to expand dedicated hybrid suites. Finally, a €120 million Series B round closed for a startup commercializing biodegradable polymer grafts, positioning it for a 2025 EU launch. These moves collectively shape the Endovascular Aneurysm Repair industry trends and signal a shift toward minimally invasive, data‑centric solutions. Analysts expect continued consolidation and the entry of tele‑monitoring platforms by 2026, further expanding market access and cost efficiency.

Analyst Overview

Overall, the Endovascular Aneurysm Repair market remains highly attractive, driven by aging populations and expanding reimbursement. Competitive intensity is moderate; a few large OEMs dominate device platforms, but niche innovators are gaining footholds through specialty grafts. The long‑term outlook is positive, with CAGR projected above 7% through 2032 as screening programs broaden and guideline adoption accelerates. Innovation is vibrant: next‑generation low‑profile systems, integrated imaging, and bio‑resorbable scaffolds are moving from early trials to commercial launch, creating differentiation opportunities. Demand continues to outpace supply in emerging regions where vascular centers are scaling up, prompting manufacturers to expand production capacity and local partnerships. Key risk factors include regulatory delays for novel materials, potential reimbursement pull‑backs, and macro‑economic pressures that could compress hospital budgets. Stakeholders should monitor these dynamics while leveraging the favorable market fundamentals highlighted in the Endovascular Aneurysm Repair market outlook. Investors and hospital networks that secure early access to next‑gen platforms will likely capture superior clinical outcomes and market share. Strategic partnerships that integrate device and data analytics are emerging as a differentiator, enabling real‑time procedural optimization and post‑operative monitoring.

11 items

1. Executive Summary

2. Endovascular Aneurysm Repair Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Endovascular Aneurysm Repair Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Endovascular Aneurysm Repair Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Abdominal Aortic Aneurysm (AAA)

6.1.2. Thoratic Aortic Aneurysm (TAA)

6.2. Global Endovascular Aneurysm Repair Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Percutaneous Evar

6.2.2. Fenestrated Evar

6.2.3. Aortic Stents & Taa Graft

6.2.4. Others

6.3. Global Endovascular Aneurysm Repair Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Endovascular Aneurysm Repair Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Endovascular Aneurysm Repair Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Endovascular Aneurysm Repair Market Competition by Key Manufacturers

8.1. Global Endovascular Aneurysm Repair Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Endovascular Aneurysm Repair: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardinal Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cook Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Endologix

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Lombard Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Medtronic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Koninklijke Philips N.V.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Terumo Medical Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. W. L. Gore & Associates

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Endovascular Aneurysm Repair Market

Figure 4: Global Endovascular Aneurysm Repair Market: Drivers

Figure 5: Global Endovascular Aneurysm Repair Market: Challenges

Figure 6: Global Endovascular Aneurysm Repair Market: Trends

Figure 7: Global Endovascular Aneurysm Repair Market: Opportunity

Figure 8: Global Endovascular Aneurysm Repair Market: Restraint

Figure 9: Global Endovascular Aneurysm Repair Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Endovascular Aneurysm Repair Market Value (USD Million) By Region

Figure 15: Global Endovascular Aneurysm Repair Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Endovascular Aneurysm Repair Market Value (USD Million) By Region

Figure 23: Global Endovascular Aneurysm Repair Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Endovascular Aneurysm Repair Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Endovascular Aneurysm Repair Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Endovascular Aneurysm Repair Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Endovascular Aneurysm Repair Market Value (USD Million) By Region

Table 10: Global Endovascular Aneurysm Repair Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Endovascular Aneurysm Repair Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Endovascular Aneurysm Repair Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Endovascular Aneurysm Repair Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Cardinal Health Basic Information And Sales Area

Table 35: Cardinal Health. Products Portfolio

Table 36: Cook Medical Basic Information And Sales Area

Table 37: Cook Medical. Products Portfolio

Table 38: Endologix Basic Information And Sales Area

Table 39: Endologix. Products Portfolio

Table 40: Lombard Medical Basic Information And Sales Area

Table 41: Lombard Medical. Products Portfolio

Table 42: Medtronic Basic Information And Sales Area

Table 43: Medtronic. Products Portfolio

Table 44: Koninklijke Philips N.V. Basic Information And Sales Area

Table 45: Koninklijke Philips N.V.. Products Portfolio

Table 46: Terumo Medical Corporation Basic Information And Sales Area

Table 47: Terumo Medical Corporation. Products Portfolio

Table 48: W. L. Gore & Associates Basic Information And Sales Area

Table 49: W. L. Gore & Associates. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Endovascular Aneurysm Repair Market Value (USD Million) By Region

Table 55: Global Endovascular Aneurysm Repair Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Endovascular Aneurysm Repair market size?

The Endovascular Aneurysm Repair market size reached approximately USD 1.25 billion in 2023, driven by rising abdominal aortic aneurysm diagnoses and expanding reimbursement coverage across North America and Europe. This baseline informs forecasts through the next decade.

2. What is the projected growth rate and future outlook for the market?

Analysts project a compound annual growth rate of 5.8% from 2024 to 2032, lifting the market to roughly USD 2.0 billion by 2032. The future outlook reflects increasing minimally invasive procedures, aging populations, and emerging device innovations in high‑growth regions.

3. Which factors are the primary drivers behind market expansion?

Key drivers include the growing prevalence of abdominal aortic aneurysms, broader insurance reimbursement, patient preference for less invasive therapy, and continuous improvements in stent‑graft durability. Additionally, physician education programs and hospital investments in hybrid operating rooms accelerate adoption.

4. What challenges could hinder market growth?

Challenges comprise high upfront device costs, limited long‑term comparative data versus open surgery, and regulatory variability across jurisdictions. Moreover, a shortage of trained interventionalists in emerging markets and concerns over device‑related endoleaks constrain broader penetration.

5. Which regions lead the Endovascular Aneurysm Repair market today?

North America remains the dominant region, accounting for over 45% of revenue, thanks to advanced healthcare infrastructure and early technology adoption. Europe follows closely, driven by strong reimbursement schemes, while Asia‑Pacific shows the fastest growth rate due to expanding middle‑class populations.

6. Who are the top companies competing in this market?

Leading vendors include Medtronic, Gore Medical, Cook Medical, W.L. Gore & Associates, and Terumo. These firms differentiate through proprietary stent‑graft platforms, extensive clinical trial portfolios, and global distribution networks, securing the majority of market share across mature and emerging economies.

7. What future opportunities are emerging for the market?

Future opportunities arise from next‑generation bio‑resorbable stent‑grafts, AI‑driven patient selection algorithms, and expansion into thoracic aneurysm indications. Partnerships with digital health firms and entry into underserved regions also promise new revenue streams and differentiated product pipelines.

8. How is technology influencing the Endovascular Aneurysm Repair market?

Advanced imaging, 3‑D printing, and robotics are reshaping device design and procedural precision, reducing operative time and radiation exposure. Real‑time navigation platforms enable personalized graft sizing, while tele‑mentoring expands expertise to remote hospitals, accelerating market penetration.

9. What is the regulatory landscape affecting product approvals?

Regulatory pathways vary: the FDA requires premarket approval with robust clinical data, while the EU follows a CE marking route emphasizing safety conformity. Emerging markets are introducing accelerated review programs, yet manufacturers must navigate post‑market surveillance and device‑specific guidelines.

Contact for Full Report

Loading report content...

Endovascular Aneurysm Repair Growth Trends & Opportunity Analysis 2033

Market Snapshot

Endovascular Aneurysm Repair Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Endovascular Aneurysm Repair Segmentation

Endovascular Aneurysm Repair Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Endovascular Aneurysm Repair market size?

2. What is the projected growth rate and future outlook for the market?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Endovascular Aneurysm Repair market today?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing the Endovascular Aneurysm Repair market?

9. What is the regulatory landscape affecting product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Endovascular Aneurysm Repair Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Endovascular Aneurysm Repair Segmentation

Endovascular Aneurysm Repair Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Endovascular Aneurysm Repair market size?

2. What is the projected growth rate and future outlook for the market?

3. Which factors are the primary drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions lead the Endovascular Aneurysm Repair market today?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing the Endovascular Aneurysm Repair market?

9. What is the regulatory landscape affecting product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation